Cambridge, UK: Cambridge Cell Networks (CCnet), a leading in-silico systems biology company is pleased to announce ToxWiz, its unique software linking genomics and proteomics data with pathways and cellular information is being used by major pharma company, AstraZeneca to predict potential pathological effects of compounds being used to treat diseases and disorders affecting the liver.
